Brepocitinib Overview & RVT-3101 Update slide image

Brepocitinib Overview & RVT-3101 Update

First Major PBM/Payer Contract Signed Initial contract provides national template for unrestricted access to VTAMA, setting it up to become the mainstay of topical treatment Effective date: October 1, 2022 Unrestricted access requiring only automatic lookback for a steroid or physician e-attestation of prior steroid use 87% of psoriasis patients use a topical steroid first line¹ $0 copay for covered claims with MyVTAMA savings card roivant 1. Analysis of Symphony Health claims data of patients diagnosed with PsO from February 2018 to January 2019 and tracked through February 2021 Dosing and Administration Apply VTAMA once a day to affected areas. Use exactly as your doctor tells you to and wash your hands after application (unless the treatment is on your hands). For questions about how to apply, patients can visit VTAMA.com/patient-experience for a video on the correct application process. About VTAMA (tapinarof) cream 1% VTAMA Cream is a steroid-free prescription medicine for adults with plaque psoriasis. It is not known if VTAMA Cream is safe and effective in children. Scan to watch our video guide to administering VTAMA VTAMA IMPORTANT SAFETY INFO Imwer instala sit need, muralesa mápacing wit, a wi tempor inciele ant ut labore et delers megre aliqus ut saer od minn veniam cu nestrud exercitatier torace laboris nisl ut a veteras slum delers sa hug at nala perstar. Excepteur sint scent 17 For investor audiences only
View entire presentation